Byoung Chul Cho, MD, PhD

Professor of Internal Medicine
Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Republic of Korea

Poster(s):

• (301) Zongertinib in patients with pretreated human epidermal growth factor receptor 2-mutant advanced non–small cell lung cancer: Beamion LUNG-1
  Wednesday, October 29, 2025